Date: 2016-04-26
Type of information: Nomination
Compound:
Company: Oxford Biomedica (UK)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On April 26, 2016, Oxford BioMedica announced the appointment of Stuart Henderson as a non-executive Director of the Company and Chair of the Audit Committee with effect from 1 June 2016. Mr Henderson joins Oxford BioMedica from Deloitte, where he was Head of European Healthcare and Life Sciences and also served on the Global Industry Team for seven years between 2004 and 2011. Prior to this he was Partner at Arthur Andersen from 1982 to 2002, where he sat on the Andersen Global Life Sciences Team as Head of Emerging Biotechnology. Mr Henderson is a former director of the Babraham Institute and currently sits as an observer on the board of OneNucleus, the Life Sciences trade body for Cambridge and London.
Financial terms:
Latest news:
